DATA UNION CAP(08375): The Dubai subsidiary has signed a contract with a Macau distributor for a total amount of 3 million US dollars.
Summit Capital (08375) announced that following the PAS roadshow hosted by the Group in Hong Kong on February 2, 2026, its Dubai subsidiary has signed a contract with a Macau distributor for a total amount of $3 million USD. The contract covers annual authorization and subscription for PAS SaaS, setup and deployment, maintenance and technical services, as well as additional services.
DATA UNION CAP(08375) announced that after hosting the PAS roadshow in Hong Kong on February 2, 2026, its Dubai subsidiary has signed a contract with a Macau distributor for a total of $3 million. The contract relates to PAS SaaS annual authorization and subscription, setup and deployment, maintenance and technical services, and additional services.
The contract will come into effect on the effective date and is expected to be completed within one year. This successful collaboration not only enhances our market position but also lays the foundation for future growth and collaboration. The directors believe that the implementation of this contract will expand the future revenue base of the group and enhance the investment return for the company and all of its shareholders.
On January 26, 2026, the group established a subsidiary in China to support the operation and sales activities of SaaS solutions and innovative digital products in China. The main functions of this subsidiary include but are not limited to developing marketing plans, expanding sales networks, upgrading and developing PAS technology.
Related Articles

XD INC (02400) spent HK$1.9458 million on February 3rd to repurchase 23,000 shares.

UNITED LAB (03933): UBT251 injection OSA indications granted clinical trial implied license.

Contemporary Amperex Technology (300750.SZ) has accumulated repurchased 15.99 million A-shares, with a total cost of 4.386 billion yuan.
XD INC (02400) spent HK$1.9458 million on February 3rd to repurchase 23,000 shares.

UNITED LAB (03933): UBT251 injection OSA indications granted clinical trial implied license.

Contemporary Amperex Technology (300750.SZ) has accumulated repurchased 15.99 million A-shares, with a total cost of 4.386 billion yuan.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


